Literature DB >> 12475394

Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.

Ingrid Nachtergael1, Pascale Vertongen, Ingrid Langer, Jason Perret, Patrick Robberecht, Magali Waelbroeck.   

Abstract

We developed previously VPAC(1) [vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP) receptor]>VPAC(2) receptor selective ligands. Replacement of the VIP-Thr(11) by an Arg(11) in these ligands contributed to their selectivity: Arg(11)-VIP had a 200-fold lower affinity when compared with VIP at VPAC(2) receptors as opposed to 3- to 5-fold higher affinity at VPAC(1) receptors. Comparison of the binding and functional properties of related VIP analogues suggested that the VPAC(1) selectivity of Arg(11)-VIP was due to the loss of a hydrogen bond between the hydroxy group of Thr residue and the VPAC(2) receptor, steric hindrance between the Arg side chain and the VPAC(2) receptor and charge attraction by the VPAC(1) receptor. Comparison of the ability of VIP analogues to activate adenylate cyclase through chimaeric VPAC(1)/VPAC(2) and VPAC(2)/VPAC(1) receptors indicated that the first extracellular receptor loop carried most of the VPAC(2) receptors' ability to discriminate VIP from Arg(11)-VIP. Based on results obtained for a truncated VPAC(2) receptor and the closely related PACAP-preferring receptor (PAC(1)) and secretin receptors, we hypothesized that Thr(11) interacted with the VPAC(2) receptor Tyr(184) (similar to the VPAC(1) receptor Phe(200) residue). The Y184F (Tyr(184)-->Phe) VPAC(2) mutant lost the ability to discriminate VIP from Val(11)-VIP, and the F200Y VPAC(1) mutant acquired the ability to discriminate the natural peptide from Val(11)-VIP. These results support the hypothesis that the hydroxy group of the native VIP-Thr(11) side chain can indeed form a hydrogen bond with the Tyr side chain in the VPAC(2) receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12475394      PMCID: PMC1223231          DOI: 10.1042/BJ20020811

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems.

Authors:  F Horn; G Vriend; F E Cohen
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Conformation of a peptide ligand bound to its G-protein coupled receptor.

Authors:  H Inooka; T Ohtaki; O Kitahara; T Ikegami; S Endo; C Kitada; K Ogi; H Onda; M Fujino; M Shirakawa
Journal:  Nat Struct Biol       Date:  2001-02

3.  Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.

Authors:  C G Park; S C Ganguli; D I Pinon; E M Hadac; L J Miller
Journal:  J Pharmacol Exp Ther       Date:  2000-11       Impact factor: 4.030

4.  Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig.

Authors:  Hisato Igarashi; Tetsuhide Ito; Wei Hou; Samuel A Mantey; Tapas K Pradhan; Charles D Ulrich; Simon J Hocart; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

5.  Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide.

Authors:  P Nicole; L Lins; C Rouyer-Fessard; C Drouot; P Fulcrand; A Thomas; A Couvineau; J Martinez; R Brasseur; M Laburthe
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

Review 6.  Molecular properties of the PTH/PTHrP receptor.

Authors:  T J Gardella; H Jüppner
Journal:  Trends Endocrinol Metab       Date:  2001-07       Impact factor: 12.015

7.  Proline residue 280 in the second extracellular loop (EC2) of the VPAC2 receptor is essential for the receptor structure.

Authors:  P Vertongen; R M Solano; M G Juarranz; J Perret; M Waelbroeck; P Robberecht
Journal:  Peptides       Date:  2001-09       Impact factor: 3.750

8.  Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction.

Authors:  R M Solano; I Langer; J Perret; P Vertongen; M G Juarranz; P Robberecht; M Waelbroeck
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

9.  The human VPAC1 receptor: three-dimensional model and mutagenesis of the N-terminal domain.

Authors:  L Lins; A Couvineau; C Rouyer-Fessard; P Nicole; J J Maoret; M Benhamed; R Brasseur; A Thomas; M Laburthe
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

10.  Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.

Authors:  J Van Rampelbergh; M G Juarranz; J Perret; A Bondue; R M Solano; C Delporte; P De Neef; P Robberecht; M Waelbroeck
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

View more
  1 in total

1.  Agnathan VIP, PACAP and their receptors: ancestral origins of today's highly diversified forms.

Authors:  Stephanie Y L Ng; Billy K C Chow; Jun Kasamatsu; Masanori Kasahara; Leo T O Lee
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.